Physician

Ali R Lakhani, MD

According to 2025 Medicare claims, Ali Lakhani, MD (NPI: 1568458107) practices hematology/oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Will, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60487-7581. Lakhani is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Lakhani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 104,266 HCPCS/CPT codes, and received $1,541,100 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 669 prescription claims across 196 beneficiaries totaling $1,589,904 in drug costs, led by Imbruvica (Ibrutinib). 2021 DME data shows 50 claims. Open Payments data shows 88 records totaling $1,928. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $347,239 to $1,541,100. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $286,662 to $1,589,904. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$901K$1.8M2015 Medicare payment: $347,239 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $297,366 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $448,020 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $952,049 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,056,750 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $944,452 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,801,241 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,243,963 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,559,747 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,541,100 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201543129,390$347,239
201637918,232$297,366
201744117,656$448,020
201842359,276$952,049
201939181,795$1,056,750
202033654,566$944,452
2021377145,799$1,801,241
202238788,651$1,243,963
2023583110,582$1,559,747
2024517104,266$1,541,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $286,662 (USD; Tot_Drug_Cst)2016 Drug cost: $851,997 (USD; Tot_Drug_Cst)2017 Drug cost: $818,623 (USD; Tot_Drug_Cst)2018 Drug cost: $878,990 (USD; Tot_Drug_Cst)2019 Drug cost: $1,192,004 (USD; Tot_Drug_Cst)2020 Drug cost: $1,870,438 (USD; Tot_Drug_Cst)2021 Drug cost: $1,895,449 (USD; Tot_Drug_Cst)2022 Drug cost: $2,006,517 (USD; Tot_Drug_Cst)2023 Drug cost: $1,347,718 (USD; Tot_Drug_Cst)2024 Drug cost: $1,589,904 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201586542$286,662
201694718$851,997
201798609$818,623
2018137863$878,990
2019144977$1,192,004
2020124907$1,870,438
2021131896$1,895,449
2022139808$2,006,517
2023151541$1,347,718
2024196669$1,589,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.4K$2.7K2017 Medicare payment: $708 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $555 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,727 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,093 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R36$708
2018N/R26$555
2019N/R57$2,727
2020N/RN/RN/R
2021N/R50$1,093
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more231429$92
80053Blood test, comprehensive group of blood chemicals302709$10
36415Insertion of needle into vein for collection of blood sample304896$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count297784$8
83615Lactate dehydrogenase (enzyme) level242411$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib26738$407,283
BrukinsaZanubrutinib25750$331,747
EliquisApixaban1335,146$99,701
XareltoRivaroxaban282,160$39,340
LetrozoleLetrozole825,864$1,838

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.88$1,928Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali R. Lakhani, MD?

Tedicare shows public-source Medicare data for Ali R. Lakhani, MD (NPI 1568458107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali R. Lakhani, MD have ACO affiliation data?

Ali R. Lakhani, MD is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Ali R. Lakhani, MD?

Ali R. Lakhani, MD is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Ali R. Lakhani, MD have Open Payments data?

Ali R. Lakhani, MD has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.